Harary Maya, DiRisio Aislyn C, Dawood Hassan Y, Kim John, Lamba Nayan, Cho Charles H, Smith Timothy R, Zaidi Hasan A, Laws Edward R
1Computational Neuroscience Outcomes Center (CNOC), Department of Neurosurgery.
2Icahn School of Medicine at Mount Sinai, New York City, New York; and.
J Neurosurg. 2018 Nov 9;131(4):1142-1151. doi: 10.3171/2018.5.JNS181054. Print 2019 Oct 1.
Loss of pituitary function due to nonfunctional pituitary adenoma (NFPA) may be due to compression of the pituitary gland. It has been proposed that the size of the gland and relative perioperative gland expansion may relate to recovery of pituitary function, but the extent of this is unclear. This study aims to assess temporal changes in hormonal function after transsphenoidal resection of NFPA and the relationship between gland reexpansion and endocrine recovery.
Patients who underwent endoscopic transsphenoidal surgery by a single surgeon for resection of a nonfunctional macroadenoma were selected for inclusion. Patients with prior pituitary surgery or radiosurgery were excluded. Patient characteristics and endocrine function were extracted by chart review. Volumetric segmentation of the pre- and postoperative (≥ 6 months) pituitary gland was performed using preoperative and long-term postoperative MR images. The relationship between endocrine function over time and clinical attributes, including gland volume, were examined.
One hundred sixty eligible patients were identified, of whom 47.5% were female; 56.9% of patients had anterior pituitary hormone deficits preoperatively. The median tumor diameter and gland volume preoperatively were 22.5 mm (interquartile range [IQR] 18.0-28.8 mm) and 0.18 cm3 (IQR 0.13-0.28 cm3), respectively. In 55% of patients, endocrine function normalized or improved in their affected axes by median last clinical follow-up of 24.4 months (IQR 3.2-51.2 months). Older age, male sex, and larger tumor size were associated with likelihood of endocrine recovery. Median time to recovery of any axis was 12.2 months (IQR 2.5-23.9 months); hypothyroidism was the slowest axis to recover. Although the gland significantly reexpanded from preoperatively (0.18 cm3, IQR 0.13-0.28 cm3) to postoperatively (0.33 cm3, IQR 0.23-0.48 cm3; p < 0.001), there was no consistent association with improved endocrine function.
Recovery of endocrine function can occur several months and even years after surgery, with more than 50% of patients showing improved or normalized function. Tumor size, and not gland volume, was associated with preserved or recovered endocrine function.
无功能垂体腺瘤(NFPA)导致的垂体功能丧失可能是由于垂体受压。有人提出腺体大小和围手术期腺体相对扩张可能与垂体功能恢复有关,但具体程度尚不清楚。本研究旨在评估经蝶窦切除NFPA后激素功能的时间变化以及腺体再扩张与内分泌恢复之间的关系。
选择由单一外科医生进行内镜经蝶窦手术切除无功能大腺瘤的患者纳入研究。排除既往有垂体手术或放射外科手术史的患者。通过查阅病历提取患者特征和内分泌功能。使用术前和术后长期(≥6个月)的磁共振成像对垂体进行体积分割。研究内分泌功能随时间的变化与包括腺体体积在内的临床特征之间的关系。
共确定了160例符合条件的患者,其中47.5%为女性;56.9%的患者术前存在垂体前叶激素缺乏。术前肿瘤直径中位数和腺体体积分别为22.5 mm(四分位间距[IQR]18.0 - 28.8 mm)和0.18 cm³(IQR 0.13 - 0.28 cm³)。在55%的患者中,至最后一次临床随访中位数24.4个月(IQR 3.2 - 51.2个月)时,其受累轴的内分泌功能恢复正常或改善。年龄较大、男性以及肿瘤体积较大与内分泌恢复的可能性相关。任何轴恢复的中位时间为12.2个月(IQR 2.5 - 23.9个月);甲状腺功能减退是恢复最慢的轴。尽管腺体从术前(0.18 cm³,IQR 0.13 - 0.28 cm³)到术后(0.33 cm³,IQR 0.23 - 0.48 cm³;p < 0.001)显著再扩张,但与内分泌功能改善无一致关联。
内分泌功能恢复可在术后数月甚至数年发生,超过50%的患者功能改善或恢复正常。与内分泌功能保留或恢复相关的是肿瘤大小,而非腺体体积。